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Pathophysiology of the cerebral circulation during cardiac surgery
Jacques Berré
Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium
Although mortality rate after cardiac surgery has been
drastically reduced, neurological complications remain a
significant problem. Several etiologic factors have been
proposed, including previous unrecognized neurological
abnormality, embolic events, hypoxic insult, low cardiac
output, systemic inflammatory response, and altered cere-
bral blood flow (CBF) and metabolism. Cerebral ischemia
can occur when cerebral oxygen is insufficient to meet the
global or regional cerebral oxygen consumption. Cerebral
circulation is normally regulated by several complex mech-
anisms, such as metabolic stimuli, chemical stimuli, perfu-
sion pressure, and neural stimuli [1].
During and after cardiac surgery, CBF and metabolism
can also be affected by other factors including arterial
PCO2, temperature, anesthesia depth, and perfusion flow
rate during cardiopulmonary bypass. As a consequence of
the effects of anesthetic agents and hypothermia, CBF is
generally reduced during cardiac surgery. Cerebral meta-
bolic regulation refers to the mechanism describing the
adaptation of CBF to the metabolic demands of the brain.
Although CBF–metabolism coupling is fairly well main-
tained during cardiopulmonary bypass, cerebral metabolic
rate for oxygen (CMRO2) decreases significantly more
than CBF [3]. The increase in CBF to CO2 is preserved
during hypothermic cardiopulmonary bypass, but the
response can be diminished when using pH-stat manage-
ment of blood gases due to the powerful vasodilator effect
of CO2 on the cerebral vasculature [4]. Moderate changes
in arterial PO2 do not significantly alter CBF, but CBF
increases once PaO2 drops below 50mmHg so that cere-
bral oxygen delivery remains constant.
Pressure autoregulation refers to the ability of the brain to
maintain total and regional CBF nearly constant despite
large changes in systemic arterial blood pressure, inde-
pendently of flow–metabolism coupling [5]. Pressure
autoregulation is generally preserved during hypothermic
cardiopulmonary bypass. Impaired autoregulation has
been reported mainly in pH-stat conditions due to
increasing PaCO2. Interestingly, CBF and metabolism
seem to be unaffected during pulsatile flow as compared
with nonpulsatile flow during cardiopulmonary bypass [6].
Different data found by other investigators may be easily
explained by changes in perfusion variables, such as tem-
perature or PaCO2. Variation in the systemic flow rate
from the pump oxygenator per se hardly influences CBF
or CMRO2 during hypothermic CPB [7]. Conflicting
results reported by others are difficult to interpret
because of confounding effects of differences in the man-
agement of CO2, and anesthetic and vasoactive drugs
during hypothermic cardiopulmonary bypass. Since blood
viscosity represents a major determinant of vascular resis-
tance, CBF is inversely related to hematocrit [8]. Never-
theless, a continuing controversy pertains to whether
CBF is purely rheologic or a function of changes in
oxygen delivery to the tissue.
In conclusion, CBF and CMRO2 drop during cardiac
surgery due to combined effects of both anesthesia and
hypothermia. Regulatory mechanisms of CBF are little
affected by hypothermic cardiopulmonary bypass, but
can be influenced by other determinants of cerebral per-
fusion.Critical Care    Vol 4 Suppl B    Abstracts of the 2ndInternational Symposium on the Pathophysiology of Cardiopulmonary Bypass
References
1. Young WL, Ornstein E: Cerebral and spinal cord blood flow. In:
Anesthesia and Neurosurgery. Edited by Cottrell JE, Smith DS. St.
Louis, MO: Mosby, 1994:17–58.
2. Murkin JM, Farrar JK, Tweed WA, et al: Cerebral autoregulation and
flow/metabolism coupling during cardiopulmonary bypass: the
influence of PaCO2. Anesth Analg 1987, 66:825–832.
3. Hindman BJ, Funatsu N, Harrington J, et al: Cerebral blood flow
response to PaCO2 during hypothermic cardiopulmonary bypass
in rabbits. Anesthesiology 1991, 75:662–668.
4. Paulson OB, Strandgaard S, Edvinsson L: Cerebral autoregula-
tion. Cerebrovasc Brain Metab Rev 1990, 2:161–192.
5. Hindman BJ, Dexter F, Ryu KH, et al: Pulsatile versus nonpul-
satile cardiopulmonary bypass. No difference in brain blood
flow or metabolism at 27 degrees C. Anesthesiology 1994,
80:1137–1147.
6. Rogers AT, Prough DS, Roy RC, et al: Cerebrovascular and cere-
bral metabolic effects of alterations in perfusion flow rate
during hypothermic cardiopulmonary bypass in man. J Thorac
Cardiovasc Surg 1992, 103:363–368.
7. Todd MM, Weeks JB, Warner DS: Cerebral blood flow, blood
volume, and brain tissue hematocrit during isovolemic hemodi-
lution with hetastarch in rats. Am J Physiol 1992,
263:H75–H82.
Neurological damage due to coagulation and fat release during cardiopulmonary bypass
Willem van Oeveren
Blood Interaction Research, Cardiothoracic Unit, University Hospital, Groningen, The Netherlands
Introduction: Cardiac surgery with cardiopulmonary
bypass (CPB) has been associated with a higher risk of
neurologic and neuropsychological deficits than other
major types of surgery [1]. Different etiologic mechanisms
have been proposed to account for these deficits [2–5].
First, inadequate perfusion of the brain circulation has
been proposed as a factor of brain damage. Second, CPB
produces a systemic inflammatory response that may give
rise to renal and pulmonary dysfunction, but the effect on
the brain has attracted less attention [6,7]. Although a
causal relationship has been suggested between the
inflammatory response and cognitive dysfunction [8], no
clear evidence exists. Third, emboli are formed during
CPB by air, clotting activity or cell aggregation and fat
release. Partly, these emboli are captured by the various
filters in the circuit, but reorganization of smaller emboli
might still occur. By comparing several studies in which
markers for brain damage were used, these three major
mechanisms are discussed.
Ischemia: During routine CPB at moderate hypothermia,
a flow of 2.5l/min m2 is applied. The question arises
regarding whether this flow is sufficient under the stress-
inducing circumstances. During CPB a whole-body inflam-
matory response is induced, with release of vasoactive
substances, which is often shown by hypotension. Simul-
taneously, a number of hormones are released, which,
under physiologic circumstances, would result in an
increased heart rate and subsequent increased flow. The
relatively low flow during CPB has been proposed to com-
pensate insufficiently, and thus to result in relative hypop-
erfusion of organs, including the brain. Although not yet
proven, this could be a factor of importance to induce
brain damage. Additionally, brain damage might be
induced to a greater extent in patients undergoing Fallot
corrections by the preceding relative hypoxemia, with
SaO2 of less than 85% changing into 100% saturation
with concomitant generation of oxygen radicals resulting
in ischemia–reperfusion damage [9].
Low temperatures seem to protect the brain, however,
because a comparison of CPB with circulatory arrest in
infants at a temperature of <18°C with continuous flow at
moderate hypothermia, did not show differences in S100b
release.
Inflammation: The systemic inflammatory reaction (SIR) is
recognized as one of the factors that causes neuropsy-
chological dysfunction after CPB. We evaluated the rela-
tionship between the SIR and S100b release.
One hundred patients undergoing coronary artery bypass
grafting were studied. Inflammatory markers were deter-
mined at several time points during and after the opera-
tion. Correlation analysis between maximum levels of the
different markers and S100b release were performed.
No overall association was found between the maximum
levels of the inflammatory markers and S100brelease.
Remarkably, the concentrations of S100b were low as
compared with previous published results.
In this context, the question arises regarding whether
S100 b is capable of identifying patients with cerebral
dysfunction after CPB. We evaluated whether periopera-
tive release of S100b after coronary artery surgery with
CPB could predict early or late neuropsychological impair-
ment [10]. Patients underwent cognitive testing on a
battery of 11 tests preoperatively, before discharge from
hospital and 3 months later. No significant correlation was
found between S100b release and neuropsychological
measures at either 5 days or 3 months postoperatively. In
this group of patients with limited release of S100b we
found no evidence to support the suggestion that early
release of S100b may reflect long-term neurological injury
capable of producing cognitive impairment.
Cardiotomy suction: In order to exclude noncerebral
sources of S100b no cardiotomy suction or retransfusion of
shed mediastinal blood was used in the previously described
study on 100 patients. The low concentrations of S100b
indicate a significant contribution of noncerebral sources of
S100b in previous studies, or a dominant role of cardiotomy
suction blood in the induction of cerebral damage.Despite heparinization of patients increases in markers for
activation of clotting, such as prothrombin fragment 1+2
(F1+2), thrombin–antithrombin (TAT) and fibrinopeptide A
(FPA), have been reported [11]. In general, most activation
products are observed in the late period of the operation,
which is thought to result from consumption of heparin,
rewarming of the patients after a period of cooling, or to
intensified pericardial suction of shed blood.
There is mounting evidence that suction blood is the major
source of increased activation of the clotting system,
which even enhances the clotting and fibrinolytic process
after retransfusion of suction blood into the systemic cir-
culation.
In infants a high percentage of multiple system organ
failure after CPB has been observed, which correlated
with increased blood activation [12]. Patients undergoing
tetralogy of Fallot are considered to be more prone to
blood activation than ventricle septum defect (VSD)
patients, because of the more extended surgery and inten-
sified suction in combination with increased bleeding due
to pre-existing disturbed hemostasis and blood dilution
during CPB. Moreover, this shed blood in infants cannot
be discarded due to the low circulating volume.
Microembolic particles produced by increased clotting
activity may obstruct the microcirculation of the brain.
Moreover, suction blood contains fat particles, which are
not removed completely by screen filters and which are
also reported to be related to the occurrence of small cap-
illary and arteriolar dilatations in the brain [13].
We found a significant correlation between the brain
damage marker S100b and F1+2 concentrations, indi-
cating activation of the clotting system, as well as
between S100b and glycerol, indicating free fat in the
circulation.
F1+2 was found to a higher extent in Fallot than in VSD,
which corresponded with higher S100b concentrations.
Conclusion: We conclude that brain damage during
CPB in infants may be induced by activation of the clot-
ting system and by release of glycerol during operation,
resulting in embolization of brain arterioles. Particularly in
patients undergoing tetralogy of Fallot, this process may
lead to brain damage.
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Markers of brain cell damage related to cardiac surgery
Per Johnsson
Department of Cardiothoracic Surgery, University Hospital of Lund, Lund, Sweden
S100 proteins belong to a family of many small proteins
[1]. The isoform S100B2 is 21kDa in size, consist of two
B-chains, and is a so called EF-hand protein with the
capacity to bind calcium. It is normally present in serum in
very low concentrations 0.03–0.12mg/l, but in high con-
centrations both extracellular and intracellular in the brain.
It has been found both in glial cells and in neurones, but is
believed to be synthesized only in glial cells. The protein is
neurotrophic and takes part in healing and maturation
processes, but can also be a trigger for apoptosis via stim-
ulation of nitric oxide synthase (NOS) and lipid peroxida-
tion pathways [2]. It can be analyzed in serum with a lumi-
nescence immunoassay (Sangtec100, AB Sangtec,
Bromma, Sweden).
In brain damage from stroke, trauma or subarachnoidal
haemorrhage, the serum concentration is associated with
the volume of cellular damage and with outcome. In global
anoxemia, as after successful (!) resuscitation, it is an early
measure of prognosis [3]. S100 can be used, to evaluate
http://ccforum.com/supplements/4/SBthe cellular involvement and prognosis in patients suffering
from stroke and after cardiac surgery. In stroke, peak con-
centrations in serum occur after about 1–3 days, depend-
ing on the heterogeneity of cell damage in focal brain
lesions. It has long been known that that S100 is released
to the bloodstream during cardiopulmonary perfusion and
that this release is associated to the duration of perfusion
[4]. Whether cellular disruption is mandatory or only an
impaired blood–brain barrier is sufficient for this release to
occur is unclear. Expectations of a possible association
between S100 levels and the neuropsychological deterio-
ration occurring after cardiac surgery has increased the
clinical interest in S100.
Reports of irregular peak levels and nonsystematical corre-
lation’s to risk factors for brain damage, perfusion times or
neuropsychological results led us to doubt the specificity
of the protein to brain tissue alone. It now seems clear that
S100 is also present in fat or mediastinal tissue. This
extracerebral source contaminates the S100 levels during
operation if cardiotomy suckers are used, and after surgery
due to the use of autotransfusion. The biological half-life of
S100 in the circulation was earlier considered to be
around 2h, but has recently been reinvestigated and found
to be only 25 min. Bearing this in mind, it is still possible to
use early serum levels of S100 for assessment of brain
damage in conjunction with cardiopulmonary perfusion.
Preliminary findings from a long-term follow up study of
patients operated on in 1996 and 1997 suggested that
S100 sampled 2 days after surgery is a strong predictor
of late mortality. Patients who are dismissed from surgery
without any suspicion of a cerebral complication, but with
an elevation of S100, seem to have a shorter life
expectancy. It can be speculated that the elevated S100
in these patients represents subclinical brain injury.
Neurone-specific enolase (NSE) is another suggested
marker of cerebral injury. However, as enolase is present
not only in neurones, but also in erythrocytes, early
increases have to be interpreted with caution. The elimina-
tion rate of free hemoglobin from the circulation is much
faster than that of NSE, which is why a simple measure of
hemoglobin is hard to use for the estimation of hemolysis
and erythrocytic contamination. Still, a number of reports
have been published where NSE has been advocated to
be a reliable marker, and I believe that there may be room
for NSE as well. However, increased efforts to character-
ize the kinetics and possible erroneous contribution from
erythrocytes have to be made first.
In children, we face other problems. The normal concen-
trations of S100 cannot be used in children. S100 levels
are higher and it is not clear whether this is a function of
imperfection of the blood–brain barrier or ongoing matura-
tion processes in the brain. Likewise, there seem to be dif-
ferences between cyanotic and acyanotic babies. 
A biochemical marker of brain dysfunction/damage would
of course make the evaluation of surgical techniques
much easier, compared with ‘the gold standard’ of
prospective neuropsychological or morphological investi-
gations such as magnetic resonance imaging. However, it
is not justified to expect congruent results with these three
methods. One should instead see the three as comple-
mentary, although the biochemical marker would be an
ideal and simpler screening method, both for the risk
assessment in individual patients and for the assessment
of new techniques. The number of published articles on
the issue of biochemical markers is rapidly increasing. It is
therefore reasonable to believe that some of the problems
we face today will be overcome by increased research
efforts.
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Neurological complications after cardiac surgery in adults
Mark F Newman
Division of Cardiothoracic Anesthesiology, Department of Anesthesiology, Duke Heart Center, Duke University Medical Center,
Durham, North Carolina, USA
Although the number of patients undergoing surgery for
valvular and other types of heart disease has remained
fairly constant, the number undergoing coronary revascu-
larization procedures is rising. Thanks to many technologi-
cal advances over the past four decades, there has been a
steady fall in both the mortality and morbidity associated
with these procedures. Despite this fact, neurological
injury remains an important cause of postoperative mor-
bidity and is responsible for an increasing proportion of
perioperative deaths. Advancing age and atherosclerosis
make the more than 800000 patients a year that undergo
cardiac surgical procedures worldwide that are particu-
larly prone to neurological morbidity. Since the introduc-
tion of cardiopulmonary bypass (CPB) in the early 1950s,
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Fenella J Kirkham
Institute of Child Health, The Wolfson Centre, London, UK
Advances in surgical and cardiopulmonary bypass tech-
niques mean that it is now possible to definitively repair
the vast majority of congenital heart disease in infancy or
childhood. Although the majority of survivors do not have
obvious cerebral sequelae, there is increasing disquiet
about the high incidence of acute neurological events in
the immediate postoperative period, as well as the evi-
dence at long-term follow-up that there are subtle cogni-
tive and motor deficits in many.
Some children are more at risk of neurodevelopmental
problems, either because of their cardiac (egextensive aor-
topulmonary collaterals) or cerebrovascular (eg the propen-
sity to large vessel dissection) anatomy or because of
genetic predisposition (eg to prothrombotic disorders). The
incidence may vary with the surgery (eg the Fontan opera-
tion) and the cardiopulmonary bypass technique necces-
sary to achieve an adequate technical repair (eg low or no
flow at deep hypothermia). Recognition of the population at
risk will lead to prevention of serious sequelae. Data col-
lected in adults may be misleading, and many paediatric
units have developed their own practice, but recent studies
in animal models of infant surgery and in children have pro-
duced some evidence to guide management to ensure the
optimal cerebral as well as cardiac outcome.
Pump flow should be maintained at least 30ml/kg per min
where possible, with inotropic support to maintain blood
pressure if necessary. If pump flow must go lower or circu-
latory arrest is essential, thorough cerebral cooling to
deep hypothermic temperatures is mandatory; a pH-stat
strategy may make this easier, but an a-stat strategy may
be better in those operations that can be performed at
moderate hypothermia. There is no evidence that the avail-
able pulsatile pumps offer an advantage. Tissue oxygena-
tion may reach critical levels and a high haematocrit and
oxygen tension may reduce the risk of significant hypoxia.
There is a risk of embolization in children, which can be
reduced with membrane oxygenators and careful monitor-
ing; the role of arterial filtration remains controversial. The
only protective agent that can be recommended at the
present time is methylprednisolone to protect the spinal
cord (eg in operations on the aortic arch). Further studies
are needed in this important area.
the neurological sequelae of cardiac surgery have been a
major concern. More recently, identification of risk factors
for adverse neurological and neuropsychological outcome
has allowed physical and pharmacological neuroprotective
strategies to be targeted at the high-risk population.
Over the past 20 years, there has been a steady increase
in the average age of patients undergoing cardiac surgery.
This increase has been accompanied by a rise in both the
severity of cardiac disease at the time of surgery and the
reoperation rate for recurrent disease. Nevertheless, the
likelihood of dying or sustaining a major complication after
cardiac surgery in the late 1990s is significantly lower
than in the 1950s. Not unreasonably, most patients expect
to survive cardiac surgery intact, make a good functional
recovery and live longer. A significant number of patients
undergoing cardiac surgery will, however, suffer a periop-
erative complication involving the central nervous system
(CNS).
Adverse neurological outcome from cardiac surgery is the
result of damage to the brain, spinal cord and/or peripheral
nerves. CNS injury ranges in severity from subtle changes
in personality, behaviour and cognitive function to fatal
brain injury – the cerebral catastrophe. A major neurologi-
cal complication after otherwise successful surgery repre-
sents a devastating outcome for both the patient and their
family. The social and economic impact is enormous.
The common occurrence of adverse CNS outcomes has
resulted in enhanced interest in strategies for cerebral
protection in cardiac surgery ranging from stratification
of an at-risk population to management of aortic athero-
sclerosis, temperature and rewarming.
Neuropsychological complications after cardiac surgery in children
David C Bellinger
Department of Neurology, Children’s Hospital, Boston, Massachusetts, USA
Although the surgical morbidity of infants who must
undergo cardiac surgery has declined, follow-up studies
have identified major neurodevelopmental abnormalities in
as many as 25% of survivors. The prevalence of subtle
dysfunctions is likely to be even higher. An important
source of morbidity may be operative events, particularly
the support techniques used to protect vital organs during
cardiac repair, including deep hypothermia with either
total circulatory arrest (TCA) or continuous low-flow car-
diopulmonary bypass (LFB). Drawing conclusions about
the central nervous system (CNS) sequelae of cardiac
surgery in children has been impeded, however, by a
variety of methodological limitations of many published
studies, including small sample sizes, diverse cardiac
http://ccforum.com/supplements/4/SBdefects and ages at repair, retrospective study design,
comparison of operative techniques used at different time
periods, and lack of uniformity in the age at which children
are followed up and in the test instruments used.
For more than a decade, our group at the Children’s Hos-
pital (Boston) has conducted studies to evaluate the CNS
sequelae among infants with congenital heart lesions. This
presentation focused primarily on the results to date of our
single-center trial of infants with d-TGA who were random-
ized to undergo the arterial switch operation at less than
3 months of age using either TCA or LFB. The original
cohort consisted of 171 infants (42 of whom also had a
ventricular septal defect). Neurodevelopmental evaluations
were completed on 155 children at 1 year of age and 158
children at 4 years of age. In addition, information was
obtained on interim developmental status by means of
parent-completed questionnaires when children were
2.5 years of age. Evaluations at age 8 years are ongoing
and have been completed for approximately 135 children.
Our findings to date suggest two major conclusions. First,
children assigned to TCA tend to have worse neurodevel-
opmental outcomes than do children assigned to LFB. In
the perioperative period, they were at increased risk of
clinical seizures; at 1 year of age, they achieved lower
scores on a standardized test of motor development
(Bayley Scales of Infant Development) and were at higher
risk of having abnormalities on neurologic examination; at
2.5 years, they had worse expressive language develop-
ment; and at 4 years of age they scored lower on tests of
gross and fine motor function, and were at increased risk
of oromotor apraxia and other abnormalities of speech
production. Treatment group comparisons at 8 years of
age will not be made until all eligible children have been
evaluated.
Our second major conclusion is that the performance of
the full cohort (ie children in both treatment groups) is
below expected levels in several specific neuropsychologi-
cal domains, placing them at substantially increased risk of
academic failure. Interestingly, on global standardized
tests such as IQ, the children’s scores tend to be well
within the normal range, although shifted slightly toward
lower values. They express substantial deficits, however, in
the following areas: visual–spatial/visual–motor skills,
working memory, hypothesis generation and testing, vigi-
lance and sustained attention, motor function, and higher-
order language skills (verbal fluency, generation of
connected discourse). We speculate that the neurodevel-
opmental vulnerabilities of children who undergo cardiac
surgery in infancy are most prominent on tasks that call
upon so-called ‘executive functions’. Such tasks require
that information be held, organized, manipulated, and inte-
grated, and that strategies be designed, implemented, and
modified in service of a goal.
One possibility is that a long period of cardiopulmonary
bypass, regardless of whether or not TCA is involved, is
detrimental to CNS development. Data from a small non-
randomized study that are consistent with this hypothesis
is presented. Children with atrial septal defects (ASDs)
that were closed surgically scored significantly lower than
children with ASDs that were closed by means of a
catheter-delivered device, particularly in terms of
visual–spatial skills. A randomized trial comparing the neu-
ropsychological sequelae of surgical and transcatheter
closure of ASDs is planned.
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circulatory arrest
S Voqt, D Troitzsch, H Abdul-Khaliq, PE Lange and R Moosdorf
Klinik für Herzchirurgie, Philipps-Universität Marburg/Lahn, Marburg/Lahn, and Klinik für Angeborene Herzfehler-
Kinderkardiologie, Deutsches Herzzentrum Berlin, Berlin, Germany
Objective: More recent studies have suggested that deep
hypothermic cardiocirculatory arrest (DHCA) results in
metabolic abnormalities with detrimental effects on
enzyme function and membrane stability after rewarming,
which may be associated with an increased risk for neuro-
cellular injury. We evaluated whether brain tissue oxygen
pressure (ptiO2) showed sign of cellular hypoxia during
cardiopulmonary bypass (CPB) with 1h of DHCA and
monitored changes in global cerebral blood flow (CBF) in
a rabbit model.
Methods: Ten New Zealand white rabbits (body weight
2.5±0.5 kg) were included in this study. Anesthetized and
ventilated rabbits were placed on CPB (a-stat strategy)
utilizing a membrane oxygenator with nonpulsatile pump
flows of 150–200ml/kg body weight per min for induction
of DHCA by active cooling to 15°C rectal temperature.
Rewarming was started after 1h of complete DHCA. Brain
tissue oxymetry with a microsensor catheterprobe (Licox)
in the frontoparietal cortex and CBF-measurement using
the hydrogen clearance technique were obtained at base-
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P1 Early immunohistochemical brain overexpression of S-100b b and increased serum level after deep
hypothermic circulatory arrest in rabbits: relationship to perivascular astrocytic swelling
Hashim Abdul-Khaliq, Stephan Schubert, Gesila Stoltenburg-Didinger, Michael Hübler, Wolfgang Böttcher, Dirk Triotzsch,
Roland Hetzer, Peter E Lange
Deutsches Herzzentrum Berlin and Institute of Neuropathology, Klinikum Benjamin Franklin, Free University of Berlin, Berlin,
Germany
Introduction: Understanding the pathophysiology and
neuropathological changes that might be related to brain
injury after surgical cardiac procedures using hypothermic
cardiopulmonary bypass (CPB) with a period of circulatory
arrest (TCA) is fundamental to the development of hemo-
dynamic and pharmacological neuroprotective interven-
tions. Therefore, the aim of this study was to evaluate the
relationship between the regional immunohistochemical
expression of S-100b in the brain and the serum kinetic
patterns in rabbits undergoing CPB with a 60-minute
period of TCA, followed by reperfusion and rewarming.
Methods: Fourteen New Zealand rabbits (body weight
3.1±0.25kg) were anaesthetised, intubated and mechan-
ically ventilated. Four animals were not connected to the
CPB and were used as controls. Ten animals were per-
fused after aortic and right atrial cannulation according to
a uniform protocol: full-flow CPB (150–200mL/kg per
min), PCO2 uncorrected for hypothermia (a-stat blood gas
management). After surface cooling and the establishment
of a hypothermic rectal temperature of 14°C, TCA was
induced for 60 min. The animals were then reperfused and
rewarmed over 60 min to achieve a normal rectal tempera-
ture of 38°C. The animals were weaned from bypass and
killed. The brain was immediately removed, cut in stan-
dardized sections and fixed in formaldehyde. Astrocyte
reactivity was evaluated immunocytochemically by the use
of monoclonal mouse primary antibodies to S-100b
protein (DPC Immustain, code CKS1S). The serum con-
centrations of S-100b were analysed using a commercially
available LIA kit (Byk-Sangtec, Dietzenbach, Germany)
Results: In all experimental animals a significant increase
of the serum concentration of the astrocytic protein
S-100b was found immediately after reperfusion and the
termination of CPB. In comparison with the control animals
increased expression of S-100b was found in the astroglial
cells and astrocytic dendrites in the perivascular regions. A
distinctive pathognomonic morphological cell injury that
exhibited a marked swelling of the perivascular astrocytic
cell dendrites were also found by electron microscopy from
the cerebral capillaries in the hypocamppus in the experi-
mental animals. There were less signs of neuronal cell
injury of neurons in the hippocampus formation.
Conclusion: Astrocytic activation and S-100b overexpres-
sion seem to precede the neurodegeneration following
global cold ischemia. The marked perivascular cell swelling
may support the assumption of reperfusion injury of the
astroglial cell complex that forms the blood–brain barrier
(BBB), which may be indicative of the source of the released
S-100b into the bloodstream. The early significant increased
serum levels of S-100b may provide information on possible
ongoing related injury in neuronal cell in patients after
cardiac surgery as well, who potentially benefit from neuro-
protective interventions. The function and exact release
mechanism of the S-100b through the BBB into the blood in
this respect, however, need further explanation.
http://ccforum.com/supplements/4/SBline, during cooling, resumption of CPB and systemic
rewarming, and finally while off CPB and with stable
hemodynamics.
Results: Under baseline conditions, ptiO2 was
38±15mmHg and changed to 40±11mmHg before the
onset of DHCA. The CBF was lower than baseline before
DHCA. During circulatory arrest the ptiO2 decreased
within 15 min to 14±5mmHg, after 30 min to 5±1mmHg
and after 40 min to zero. Neither the ptiO2 nor CBF recov-
ered fully during rewarming. After rewarming and termina-
tion of CPB the ptiO2 (25±6mmHg versus baseline
38±15mmHg;  P<0.05) and CBF (43±8 versus
68±11ml/100g per min; P<0.05) were significantly
reduced compared with pre-CPB values. Arterial and
jugular–venous lactate levels increased after rewarming
(P<0.05) and corresponded to the appearance of anaer-
obic metabolism.
Conclusion: These observations suggest a persistent neu-
rocellular function suppression after rewarming and a gen-
erated low-flow situation leading to transient regional
cerebral tissue hypoxia events. Delayed brain tissue reoxy-
genation after DHCA may be attributable to excessive
metabolic demand (compensation of an oxygen debt), inad-
equate tissue blood redistribution with reduced capillary
perfusion, or oxygen utilization disturbances (mitochondrial
dysfunction, reversibly inhibition of enzyme activity,
immunoreactivity for specific proteins and cytochrome
oxidase).
P3 Influences of pre-, peri- and postoperative risk factors in neonatal cardiac surgery on
neurodevelopmental status in preschool-age children
HH Hövels-Gürich, M-C Seghaye, M Sigler, A Bartl*, F Kotlarek†, J Neuser*, BJ Messmer‡ and G von Bernuth
Departments of Paediatric Cardiology, *Clinical Psychology, †Paediatric Neurology, and ‡Thoracic and Cardiovascular Surgery,
Aachen University of Technology, Aachen, Germany
Objective: Neurodevelopmental outcome in preschool-
age after neonatal arterial switch operation, in relation to
prospectively evaluated cerebral risk factors, including
durations of the support strategies and serum levels of
the marker enzyme neuron-specific enolase is assessed.
Methods: Thirty-three unselected children operated on
as neonates with combined deep hypothermic circulatory
arrest and low flow cardiopulmonary bypass were exam-
ined at an age of 3.0–4.6 years [3.6±0.5 (mean ±stan-
dard deviation)]. The control group for developmental
outcome consisted of 32 age-matched healthy children,
who were 3.0–4.8 years [3.8±0.6 (mean ±standard devi-
ation)] of age. Evaluation of socioeconomic status and a
standardised test comprising all areas of child develop-
ment (Vienna developmental test), including scores of
motor and cognitive functions, perception, language,
learning and behaviour, were carried out in patients and
controls, and clinical neurological status was assessed in
patients. Results of patients were related to those of the
control group and to pre-, peri-, and postoperative cere-
bral risk factors of the control group and to pre-, peri-,
and postoperative cerebral risk factors as described in
the context.
Results: Neurological impairment was more frequent
(6.1%) than in the normal population. Compared with
published norms, complete developmental score and the
subtests for motor function, visual perception and visual
motor integration, learning and memory, cognitive func-
tion, language, and socioemotional functions were not dif-
ferent. Compared with the control group, complete devel-
opmental score, cognitive score and language were
reduced (P<0.01), but socioeconomic status was signifi-
cantly lower in the patient group (P=0.0001). Motor
function was weakly, but significantly inversely related to
the duration of circulatory arrest (Pearson correlation
coefficient –0.37; P=0.049), but not to the duration of
bypass. The other developmental parameters were not
related to the duration of the support techniques. Serum
levels of the biochemical marker neuron-specific enolase,
although significantly elevated at the end of bypass
(P=0.0002) and 4h after surgery (P=0.0012) com-
pared with preoperative values, were not correlated to
developmental test results. No correlation was found
between the test results and the following cerebral risk
factors: protracted birth, perinatal asphyxia, peri- and
postoperative cardiocirculatory insufficiency, enhanced
cerebral echogenicity in the choroid plexus and ventricu-
lar system, and clinical seizures.
Conclusions: Neonatal arterial switch operation with
combined circulatory arrest and low flow bypass is asso-
ciated with increased neurological impairment. Develop-
mental status, based on formal testing of motor, cognitive,
language and behavioural functions, however, was not
found to be different from a that in normal population.
Outstanding results in our control group are probably
related to differences in socioeconomic status. Periopera-
tive serum levels of the neuron-specific enolase in
neonates, in our experience, are not a valid marker with
respect to later developmental outcome.
Critical Care    Vol 4 Suppl B    Abstracts of the 2ndInternational Symposium on the Pathophysiology of Cardiopulmonary BypassObjective: To analyze the occurrence of postoperative
neurological complications, defined as cerebrovascular
accident (CVA) and transient ischemic attack (TIA), after
myocardial revascularisation, in relation to pre- and periop-
erative variables.
Methods: We analyzed the pre-, peri-, and postoperative
data of 3834 patients who underwent primary isolated
bypass grafting between January 1987 and December
1995. Unifactor risk analysis was used to identify which of
the variables was a risk factor for neurological complica-
tions. Which of these variables contribute independently
was analysed using multifactor risk regression analysis. A
c2 test was used to identify which independent predictor
changed with time. The studied period of 9 years was
divided into three time cohorts of 3 years each.
Results: The incidence of neurological complications was
32/3834 patients (0.8%), and increased from 0.6% over
0.8% to 1.1% during studied period. Unifactor analysis
identified the following as risk factors: age >75 years
(P=0.008), peripheral vascular atherosclerosis or opera-
tion (carotid; P=0.002), preoperative neurological pathol-
ogy (P=0.003), perioperative detected aortapathology
(P<0.0001) and perioperative myocardial infarction
(P=0.01). Multifactor risk regression analysis identified
preoperative neurological pathology (P=0.02), periopera-
tive detected aortic pathology (P=0.0001), and a periop-
erative myocardial infarction (P=0.04) as independent
predictors for postoperative neurological complications. In
the three time cohorts there was a statistically significant
change of prevalence for preoperative neurological pathol-
ogy (P=0.02) and perioperatively detected aortic pathol-
ogy (P=0.001).
Conclusion: Preoperative neurological pathology, perioper-
ative myocardial infarction, but primarily aortapathology
were identified as independent risk factors for postoperative
CVA and/or TIA after myocardial revascularization. On the
basis of these results the use of transoesophageal echocar-
diography for detection of aorta pathology in risk patients
and single aorta cross-clamping should be strongly advised.
P4 Predictors of cerebrovascular accident and transient ischemic attack after myocardial
revascularisation
L Noyez, SH Skotnicki, DPB Janssen, JAM van Druten* and LK Lacquet
Department of Thoracic and Cardiac Surgery and *Department of Medical Informatics, Epidemiology, and Statistics, University
Hospital of Nijmegen, Nijmegen, The Netherlands
P5 Cardiopulmonary bypass using heparin surface treatment: influence on memory and neurological
deviations
S Svenmarker, E Sandström, T Karlsson, S Häggmark, E Jansson, M Appelblad, R Lindholm and T Åberg
Heart Centre, Department of Surgery & Perioperative Sciences, University Hospital, Umeå, Sweden
Objectives: Cerebral dysfunction associated with cardiac
surgery and cardiopulmonary bypass (CPB) manifested as
focal ischemic injury and diffuse encephalopathy is a dev-
astating complication. Emboli from the surgical field and
hypoperfusion have been suggested as possible causes.
The present investigation was undertaken in order to
investigate the role of heparin coatings in CPB as means
of ameliorating neurological trauma.
Methods: Three hundred patients admitted for routine
aorta-coronary bypass surgery were prospectively ran-
domized into four groups based on Carmeda Bioactive
Surface and Baxter Duraflo II coatings (ACT >250 s) for
CPB, each with an assigned uncoated control (ACT
>500s). Outcome was determined as clinical neurologi-
cal deviations, release of S100, perioperative implicit and
explicit memory performances, with a questionnaire follow
up after 4 months.
Results: The incidence of clinical neurological deviations
ranged from 4 to 8%, with no intergroup differences
(P=0.738). Concentration of S100 was significantly
(P=0.001) elevated (0.76±0.03mg/l) in all four groups
during CPB and remained so (0.39±0.03mg/l) 7h post-
operatively. A notably higher release of S100 per CPB
was observed in the Baxter control group (P<0.05). No
perioperative differences in implicit and explicit memory
function between groups were detected. At 4 months,
patients in the Baxter control group reported a more
depressed memory (P<0.05) than did those in other
groups. Memory function as experienced by next of kin
demonstrated no intergroup differences, however.
Conclusions: The role of heparin coating in CPB as a
tool to prevent memory dysfunction and neurological
deviations is not conclusive, despite a less favourable
outcome in terms of S100 release and subjective rating
of memory function for patients in the Baxter uncoated
control group.
http://ccforum.com/supplements/4/SBP6 Neuropsychologic dysfunction after CABG: standard cardiopulmonary bypass versus off-pump
CABG
I Oudenaarde, JJM Takkenberg, E van der Velden, L Chalfont*, K Wesnes*, LA van Herwerden
Heart Center, Dijkzigt University Hospital, Rotterdam, The Netherlands, and *Cognitive Drug Research Ltd, Reading, UK
Objectives: With the introduction of lesser invasive strate-
gies in cardiac surgery that do not require cardiopul-
monary bypass (CPB), it is expected that the incidence of
postoperative neuropsychologic disorders will decrease.
The difference in effect on postoperative neuropsycho-
logic dysfunction in patients undergoing coronary artery
bypass grafting (CABG) using CPB or off-pump surgery is
investigated.
Method: 10 patients undergoing standard CABG with
CPB (CABG-group; nine male/one female) and 17
patients receiving off-pump CABG without CPB (OPCAB-
group; 13 males/four females) were evaluated preopera-
tively, 7 days postoperatively and 1 month postoperatively.
The CDR computerised test battery was administered and
included single and choice reaction time, number vigi-
lance, memory scanning, and word and picture recogni-
tion. Overall cognitive ability within and between the two
groups was analyzed using one sample t-tests and analy-
sis of variance. 
Results: Mean age was similar [CABG 61.2 years, stan-
dard deviation (SD) 9.1; OPCAB 58.0 years, SD 8.9;
P=not significant). Preoperative left ventricular function
was similar (ratio impaired/good: CABG 3/10 and
OPCAB 3/17; P=not significant). In the CABG group,
two patients had prior cardiac surgery. The average
number of distal anastomosis was 3.4 (SD 0.7) for CABG
and 1.4 (SD 0.5) for OPCAB (P<0.001). Preoperatively
there were no significant differences between the two
groups on any of the tasks. At both 7 and 30 days postop-
eratively a significant difference in overall cognitive func-
tion between the CABG and OPCAB group was
observed. In the CABG group a pattern of cognitive func-
tion decline was seen at 7 days postoperatively, but this
resolved at 30 days. In the OPCAB group improvement in
cognitive function was seen at both 7 and 30 days post-
operatively.
Conclusion: CABG with the use of CPB is associated
with transient cognitive functional decline that is not
apparent using OPCAB. The increasing use of operative
techniques that do not require CPB is likely to reduce neu-
ropsychologic dysfunction. Improvement in cognitive
ability after OPCAB remains puzzling, and exploration of
unknown factors that may cause this is warranted.
P7 Norwood on the beating heart: two cases with continuous cerebral and myocardial perfusion
C Schlensak, S Johansson, T Doenst, K Sarai and F Beyersdorf 
Department of Cardiovascular Surgery, University of Freiburg, Freiburg, Germany
Objectives: The Norwood procedure is routinely per-
formed in circulatory arrest. The degree of neurological
injury from circulatory arrest is directly related to the dura-
tion of arrest time. We report a technique of selective cere-
bral and myocardial perfusion with the aim to reduce
ischemic damage to brain and heart.
Method: We performed a modified Norwood procedure on
two neonates (5 and 29 days old) with single ventricle
physiology, coarctation, and hypoplastic aortic arch. In both
cases the ascending aorta was of adequate size for arterial
cannulation. We cannulated the ascending aorta and
clamped the aortic arch distally to the innominate artery.
Aortic arch repair was performed in moderate hypothermia
with the heart beating, while both the brain and the heart
were selectively perfused.
Results: The time period of selective cerebral and myocar-
dial perfusion was 56 and 61 min, respectively. Both chil-
dren recovered uneventfully without neurological or
myocardial complications. Follow up time was 5 months.
Conclusion: The Norwood procedure can successfully be
performed without total circulatory arrest, but with protec-
tion of both brain and heart by continuous, selective perfu-
sion.
P8 Cerebral mitochondrial and regional haemoglobin saturation patterns during and after profound
hypothermic circulatory arrest in neonatal piglets
Hashim Abdul-Khaliq, Stephan Schubert, Michael Hübler, Dirk Triotzsch, Wolfgang Böttcher, V Alexi-Meskhishvili, 
Michael Kopitz, Hermann Kuppe, Gisela Stoltenburg-Didinger, Roland Hetzer and Peter E Lange
Deutsches Herzzentrum Berlin, Institute for Neuropathology, Free University Berlin, Berlin, Germany
Introduction: Total circulatory arrest (TCA) in deep
hypothermia used in corrective surgery of complex car-
diovascular malformations in children has been claimed to
cause brain injury and altered psychomotor development.
Critical Care    Vol 4 Suppl B    Abstracts of the 2ndInternational Symposium on the Pathophysiology of Cardiopulmonary BypassNear infrared spectroscopy (NIRS) allows in vivo determi-
nation of changes in cerebral oxygenated (HbO2), deoxy-
genated (Hb), and total haemoglobin (Hbt; the sum of
Hb+HbO2). Relative changes in the redox state of
cytochrome oxydase (cyt.aa3), the terminal enzyme in the
mitochondrial respiratory chain, may provide information
about the availability of oxygen at cellular level. The new
tissue oxygenation index (TOI) provides information on
the global tissue oxygenation. Measurement of protein S-
100 is used as a marker of astroglial cell injury. Thus,
change in intravascular and intracellular oxygenation
states were measured by NIRS during and after TCA in a
neonatal piglet model.
Method: Fourteen neonatal piglets (age >10 days, weight
1.9±0.25kg) were anaesthetised, intubated and mechan-
ically ventilated. Cardiopulmonary bypass (CPB) was per-
formed using a uniform perfusion method: full flow CPB
(200ml/kg per min), minimal temperature (14±1.3°C),
pCO2 uncorrected for hypothermia (a-stat method). TCA
was induced after establishment of a hypothermic rectal
temperature of 14–16°C. After warm reperfusion, the
animals were weaned and monitored for 8h. Cerebral oxy-
genation monitor (Hamamatsu 300, Herching-Deutsch-
land) was used to obtain online measurement of cerebral
oxidation parameters. Simultaneous hemodynamic para-
meters were continuously documented. 
Results: In all animals significant initial increase in HbO2,
Hbt and TOI, and fall in cyt.aa3 and Hb were found during
cooling on bypass. After induction of TCA in deep hypother-
mia a significant initial continuous parallel decrease in
HbO2, Hbt, TOI and cyt.aa3, and increase in Hb, followed
by a plateau trend without further significant change, were
found. An initial restoration of the oxidation parameters was
associated with reperfusion and rewarming. However, after
the end of reperfusion the oxygenation parameters, particu-
larly cyt.aa3 and TOI were significantly reduced for 60 min.
Conclusion: Distinct related changes in intravascular and
intracellular cerebral oxygenation patterns were found
during cooling and after TCA. The delayed recovery of
cyt.aa3 signal after TCA may indicate increased oxygen
demand after hypothermic TCA.
P9 Na+/K+-ATPase activity in the erythrocytes of infants after normothermic and deep hypothermic
low-flow cardiopulmonary bypass
D Troltzsch, H Abdul-Khaliq, S Vogt, PE Lange and R Moosdorf
Klinik für Angeborene Herzfehler-Kinderkardiologie, Deutsches Herzzentrum Berlin, Klinik für Herzchirurgie, Philipps-Universität
Marburg/Lahn, Marburg/Lahn, Germany
Objectives: Previous studies reported impairments of
membrane-bound ionic pumps as a result of membrane
damage and changes in brain tissue enzyme activity corre-
lated with the progression of cerebral morphological
changes and increased permeability of brain microvessels.
The aim of the present study was to assess whether an
alteration of Na+/K+-ATPase activity after normothermic
and deep hypothermic low-flow cardiopulmonary bypass
(CPB) is also detectable on paediatric erythrocytes (RBC)
membranes in cerebral venous blood samples.
Method: After IRB approval and informed consent, 20
infants and children were grouped as follows: 1, deep
hypothermic low-flow cardiopulmonary bypass (DHCPB;
n=10, rectal temperature 16.7±3.1°C), and 2, normoth-
ermic CPB (rectal temperature 35.2±0.8°C). Age and
weight were 3.2±2.9 months and 3.8±0.5kg for group
1, and 6.9 ± 1.4 months and 5.8±1.9kg for group 2. Two
hundred ml heparinized blood samples were obtained from
an jugular bulb catheter before the induction of CPB, at
1h (immediately after CPB termination), and subsequently
at 2, 3 and 4h postoperatively. The protein content of
haemoglobin-free erythrocyte membranes (ghosts) was
determined and the linear rate of NADH-oxidation was
measured for 10 min at 340nm. The enzyme activity was
calculated from the difference of NADH-oxidation in the
absence and in the presence of 1mmol/l ouabain. One
unit Na+/K+-ATPase represents 1nmol ATP degrada-
tion/mg protein perh.
Results: The Na+/K+-ATPase activity pre-CPB was higher
in the DHCPB-group (419±15.2 versus 329±20.5). In
the early postoperative phase the Na+/K+-ATPase activity
was restored to prebypass levels in group 2, but remained
decreased in group 1 (P<0.05) compared with preby-
pass. Plasma monovalent cationic levels did not alter sig-
nificantly during the observation period.
Conclusion: The decrease in Na+/K+-ATPase activity of
RBC membranes in infants during the early postoperative
period after deep hypothermic CPB is detectable and indi-
cate an alteration of cell membrane proteins/structures
(possibly due to hypoxic stress or lipid peroxidation). The
RBC membrane Na+/K+-ATPase measurements appears
to be an sensitive marker of subtle cerebral deterioration.
http://ccforum.com/supplements/4/SBP10 The effect of continuous treatment of the NO liberator sodium nitroprusside on the serum
kinetics of the brain marker protein S-100 in infants and children undergoing corrective cardiac
surgery with cardiopulmonary bypass
Hashim Abdul-Khaliq, Stephan Schubert, Vlademir Alexi-Meskhishvili, Peter E Lange, Ingolf E Blasig
Deutsches Herzzentrum Berlin, and Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
Introduction: Measurement of protein S-100 in serum –
an astrocytic calcium-binding protein – may provide infor-
mation on transient astroglial cell activation and disintegra-
tion of the related blood–brain barrier (BBB) due to
oxidative stress during and after cardiopulmonary bypass
(CPB). Conflicting results in vitro have been reported con-
cerning the neuroprotective effect of sodium nitroprusside.
We evaluated the effect of continuous treatment of the
nitric oxide (NO) liberator sodium nitroprusside on the
serum kinetics of protein S-100 in infants and children
after corrective cardiac surgery.
Method: Data on 99 children, who were treated with sodium
nitroprusside (median age 2.7 months, range 0.03–81.8
months), and on 92 children without treatment (median age
5.0 months, range 0.03–80 months) were retrospectively
analyzed. Sodium nitroprusside infusion was started after the
induction of anaesthesia and continued during and after ter-
mination of CPB with various doses according to the hemo-
dynamic status until the 48th postoperative hour. The serum
concentrations of S-100 were analyzed using a commercially
available LIA kit (Byk-Sangtec; Dietzenbach-Germany).
Results: There were no significant differences in the bypass
data between the nitroprusside-treated and nontreated
group (Table 1). In comparison with the prebypass values, a
significant similar increase in the concentration of protein S-
100 was found 2h after the termination of CPB in the nitro-
prusside-treated and nontreated infants, which decreased
during the following 48 postoperative hours. However, sig-
nificantly lower postbypass serum levels of S-100 were
found in the sodium nitroprusside-treated group after 24h
treatment (P=0.0005). The prebypass serum concentra-
tions of protein S-100 correlated significantly with bypass
time (r=0.57;  P=0.0001), cross-clamping time (r=0.50;
P=0.001) and age at operation (r=–0.41; P<0.0001). No
significant relationship was found between the intra- and
postoperative doses of natrium nitroprusside and the post-
bypass serum levels of S-100.
Conclusion: In this study the significant elevation of
serum levels of the protein S-100 may indicate increased
astroglial cell reactivity and increased S-100 passage to
the bloodstream. Longer lasting treatment with the NO lib-
erator sodium nitroprusside seemed to decrease the
release of S-100 into the bloodstream and may have
delayed protection on the BBB. The neurological signifi-
cance of such observation, however, should be evaluated
in further follow-up studies, including additional neuro-
physiological and neurodevelopment tests.
Table 1
Concentration of protein S-100 (m mg/l)
Prebypass 2 h after bypass 24h after bypass 48h after bypass
Nitroprusside-treated (n=99) 0.55±0.36 2.5±2 1.13±1.0 1.0±1.4
Nitroprusside nontreated (n=92) 0.59± 0.4 2.8± 2 1.99±2.1 1.5±2.3
Mann–Whitney test NS NS P=0.0005 P=0.08
Values are expressed as mean ±standard deviation. NS, not significant.
P11 Determination of perioperative neurologic complications in cardiac surgery by S100B and
neuron-specific enolase
D Baykut, J Schulte-Herbrüggen, A Beckmann, I Hosak and A Krian
Clinic of Thoracic and Cardiovascular Surgery, Heart Center Duisburg, Duisburg, Germany
Introduction: There is still no appropriate method to reli-
ably determine neurologic complications induced by extra-
corporeal circulation (ECC). S100B and neuron-specific
enolase (NSE) could be used as potential markers for a
perioperative neurologic dysfunction.
Objective: To evaluate changes in S100B and NSE levels
in patients after ECC and the correlation between preop-
erative and postoperative neurologic status
Patients and methods: Thirty consecutive patients (26
male/four female, median age 63.3±9.9 years, range
44–82 years) underwent coronary artery bypass grafting.
The neurologic status was examined 1 day preoperative
and 1–2 days after the ICU. Exclusion criteriawere as
follows: neurologic disorders, liver and/or kidney dysfunc-
tion, history of a neoplasm or drug and/or alcohol abuse.
Blood samples were collected at the following times:
before anesthesia; at the end of ECC; and 6, 24 and 48h
Critical Care    Vol 4 Suppl B    Abstracts of the 2ndInternational Symposium on the Pathophysiology of Cardiopulmonary Bypasspostoperatively. Immunoluminometric assays [LIA-mat
Sangtec (S100 and NSE)] were used to detect serum
marker levels.
Results: S100B and NSE were normal before ECC in 29
patients. In one, S100B was preoperatively high without
abnormal neurologic status before and after surgery.
S100B showed a peak at the end of ECC (mean
3.56mg/l), and mean NSE 6h after the operation (mean
28.25mg/l). Nineteen patients (63.4%) had still high
S100B 48h after surgery (0.42mg/l). In 14 patients
(46.6%), NSE was high (22.4 mg/l) during first 48h. Two
patients (6.6%) with elevated markers showed neurologic
symptoms: focal seizure and psychosis (n=1), hemiplegia
(n=1). 
Conclusion: There are remarkable changes in S100B and
NSE during operations with ECC. Even minor neurologic
abnormalities after cardiac surgery can be detected by
LIA. Neurologic disorders lead to elevated serum marker
levels. Patients with elevated markers must not have clini-
cally relevant neurologic symptoms.
P12 Corticosteroids reduce neuron-specific-enolase liberation after cardiopulmonary bypass in men
D Schmartz, Y Tabardel, L Barvais, A d’Hollander, JM De Smet and J Duchateau
Erasme & Brugmann University Hospital, Free University of Brussels, Brussels, Belgium
Introduction: Cardiopulmonary bypass (CPB) is associ-
ated with a significant morbidity due to central nervous
system dysfunction [1]. Part of this damage may be
related to the inflammatory response generated by CPB
[2]. Neuron-specific enolase (NSE) is a neuron-specific
enzyme that is liberated during brain injury and has
recently been proposed as a marker of cerebral
ischemia after CPB [3]. Because corticosteroids signifi-
cantly reduce the inflammatory reaction to CPB [4], we
investigated whether pretreatment with corticosteroids
can influence the liberation of NSE during CPB.
Materials and method: After institutional approval, 45
patients scheduled for nonemergency coronary artery
bypass grafting (CABG) with CPB were divided into four
groups: the control group (CTRL; n=17) received no
corticosteroids; the DXM group (n=7) received 2mg/kg
dexamethasone; and the MPS10 group (n=14) received
10mg/kg and the MPS30 (n=7) group received
30mg/kg methylprednisolone intravenously 2h before
surgery. CPB was conducted under moderate hypother-
mia (29–30°C) using a cold crystalloid cardioplegia and
a nonpulsatile flow. Anaesthesia consisted of a continu-
ous infusion of sufentanil, midazolam and pancuronium.
No aprotinin was used. We measured NSE levels before
induction of anaesthesia and 4h after CPB. For each
patient we calculated the change in NSE concentration
as follows: NSE (at 4h)–NSE (baseline). We also mea-
sured tumor necrosis factor (TNF) and interleukin (IL)-8
at the same time. There were no differences between the
groups regarding age, duration of CPB, aortic cross-
clamping time or number of grafts.
Results and discussion: The CTRL group showed a sig-
nificant increase in NSE after CPB, whereas in all three
corticosteroid groups NSE was significantly lower (Fig.1).
TNF and IL-8 liberation were significantly and equally
reduced in all three treatment groups. This suppression
of the inflammatory response might lead to less neu-
trophil adhesion and migration, resulting in less tissue
damage by proteolytic enzymes and oxygen-free radicals.
Conclusion: Corticosteroids, even at moderate doses,
are able to reduce the amount of NSE liberation during
CPB. This may indicate less brain injury during CPB.
Whether this reduction in NSE liberation translates into
improved neurological outcome remains to be studied.
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Figure 1
Neuron-specific enolase (NSE) levels. The control group (CTRL;
n = 17) received no corticosteroids; the DXM group (n = 7) received
2 mg/kg dexamethasone; and the MPS10 group (n = 14) received
10 mg/kg and the MPS30 (n = 7) group received 30 mg/kg
methylprednisolone intravenously 2 h before surgery. *P < 0.05 
versus CTRL group, by Mann–Whitney U-test.
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